Review of the year 2022 - Helmholtz Munich

Every day here at Helmholtz Munich, we work hard to discover breakthrough innovations for a healthier society. In our research, we focus on environmentally related diseases, such as obesity, diabetes, allergies, asthma, and other lung diseases, but also the impact of climate change on human health. We are accelerating our biomedical research with cutting-edge methods, including artificial intelligence, bioengineering, and other key technologies. Explore more about our discoveries and major successes in 2022:

• Diabetes Type-1
• Diabetes Type-2 & Obesity
• Decoding the oat genome
• New drug candidate against brain tumors
• Gene therapy against beta-thalassemia
• Vaccine against the Epstein-Barr Virus
• Therapeutic vaccine to cure hepatitis B